The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Intracellular MLCK1 diversion reverses barrier loss to restore mucosal homeostasis
Open accessAbstract
Epithelial barrier loss is a driver of intestinal and systemic diseases. Myosin light chain kinase (MLCK) is a key effector of barrier dysfunction and a potential therapeutic target, but enzymatic inhibition has unacceptable toxicity. Here, we show that a unique domain within the MLCK splice variant MLCK1 directs perijunctional actomyosin ring (PAMR) recruitment. Using the domain structure and multiple screens, we identify a domain-binding small molecule (divertin) that blocks MLCK1 recruitment without inhibiting enzymatic function. Divertin blocks acute, tumor necrosis factor (TNF)-induced MLCK1 recruitment as well as downstream myosin light chain (MLC) phosphorylation, barrier loss, and diarrhea in vitro and in vivo. Divertin corrects barrier dysfunction and prevents disease development and progression in experimental inflammatory bowel disease. Beyond applications of divertin in gastrointestinal disease, this general approach to enzymatic inhibition by preventing access to specific subcellular sites provides a new paradigm for safely and precisely targeting individual properties of enzymes with multiple functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, they provided the evidence that treatment with divertin regulate paracellular transport rather than transcellular transport across the membranes.”
From Regulation of Intestinal Barrier Function by Microbial Metabolites (2021) · cites this paper as [191]
In the citing paper
“Further, they showed that treatment with divertin blocked acute interferon gamma–primed TNF-induced MLC phosphorylation and barrier loss in Caco-2 monolayers model system.”
From Regulation of Intestinal Barrier Function by Microbial Metabolites (2021) · cites this paper as [191]
In the citing paper
“Treatment with divertin also reduced the progression and severity of experimental chronic colitis of T cell transfer model (CD4+ effector T cells in immunodeficient mice) by correcting gut permeability.191”
From Regulation of Intestinal Barrier Function by Microbial Metabolites (2021) · cites this paper as [191]
In the citing paper
“Further, they demonstrated that treatment with divertin corrected increased intestinal permeability in IL-10–/– mice (spontaneous colitis model) without significant systemic, mucosal, or epithelial toxicity.191”
From Regulation of Intestinal Barrier Function by Microbial Metabolites (2021) · cites this paper as [191]
In the citing paper
“It was shown by the Turner group that a domain binding small molecule called “divertin” blocks the recruitment of MLCK1 without inhibiting enzyme function.191”
From Regulation of Intestinal Barrier Function by Microbial Metabolites (2021) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Overview of the CCP 4 suite and current developments
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D. M., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,248
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Self-citationThe Immunoglobulin Superfamily: Domains For Cell Surface Recognition
Williams, A., & Barclay, A. N. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.002121 · Cited by 2,270
A chemical method for fast and sensitive detection of DNA synthesis in vivo
Salic, A. N., & Mitchison, T. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712168105 · Cited by 1,859
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
The intestinal epithelial barrier: a therapeutic target?
Odenwald, M. A., & Turner, J. R. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.169 · Cited by 1,288
Self-citationPowrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L., & Coffman, R. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90045-0 · Cited by 1,146
Cited by
Sorted by citations
Regulation of Intestinal Barrier Function by Microbial Metabolites
Ghosh, S., Whitley, C. S., Haribabu, B., & Jala, V. R. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.02.007 · Cited by 835
Paracellular permeability and tight junction regulation in gut health and disease
Horowitz, A., Chánez-Paredes, S. D., Haest, X., & Turner, J. R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00766-3 · Cited by 748
Self-citationTight Junction Structure and Function Revisited
Otani, T., & Furuse, M. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.08.004 · Cited by 669
The intestinal barrier: a pivotal role in health, inflammation, and cancer
Neurath, M. F., Artis, D., & Becker, C. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(24)00390-x · Cited by 593
Gut barrier disruption and chronic disease
Martel, J., Chang, S.-H., Ko, Y.-F., Hwang, T.-L., Young, J. D., & Ojcius, D. M. (2022) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2022.01.002 · Cited by 514
Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
Fugger, L. H., Jensen, L. T., & Rossjohn, J. (2020) · Cell · doi:10.1016/j.cell.2020.03.007 · Cited by 415
Increased Intestinal Permeability is Associated with Later Development of Crohn's Disease.
Turpin, W., Lee, S.-H., Garay, J. A. R., Madsen, K. L., Meddings, J., Bedrani, L., Power, N., Espin-Garcia, O., Xu, W., Smith, M. I., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.005 · Cited by 275
Self-citationBiological Function of Short-Chain Fatty Acids and Its Regulation on Intestinal Health of Poultry
Liu, L., Li, Q., Yang, Y., & Guo, A. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.736739 · Cited by 356
Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?
Villablanca, E. J., Selin, K., & Hedin, C. R. H. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00604-y · Cited by 269
GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis
Rana, N., Privitera, G., Kondolf, H. C., Bulek, K., Lechuga, S., Salvo, C. D., Corridoni, D., Antanaviciute, A., Maywald, R. L., Hurtado, A. M., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.024 · Cited by 225
Vitamin D and intestinal homeostasis: Barrier, microbiota, and immune modulation
Fakhoury, H. M. A., Kvietys, P. R., Al-Kattan, W., Anouti, F. A., Elahi, M. A., Karras, S. Ν., & Grant, W. B. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105663 · Cited by 212
Tight junctions as targets and effectors of mucosal immune homeostasis
Zuo, L., Kuo, W.-T., & Turner, J. R. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.04.001 · Cited by 191
Self-citationWoznicki, J. A., Saini, N., Flood, P. F., Rajaram, S., Lee, C. M., Stamou, P., Skowyra, A., Bustamante-Garrido, M., Regazzoni, K., Crawford, N., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04151-3 · Cited by 203
Tight junctions: from molecules to gastrointestinal diseases
Moonwiriyakit, A., Pathomthongtaweechai, N., Steinhagen, P. R., Chantawichitwong, P., Satianrapapong, W., & Pongkorpsakol, P. (2022) · Tissue Barriers · doi:10.1080/21688370.2022.2077620 · Cited by 151
A short guide to the tight junction
Citi, S., Fromm, M., Furuse, M., González‐Mariscal, L., Nusrat, A., Tsukita, S., & Turner, J. R. (2024) · Journal of Cell Science · doi:10.1242/jcs.261776 · Cited by 161
Self-citationHe, W., Wang, J., Sheng, J.-Y., Zha, J., Graham, W. V., & Turner, J. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030993 · Cited by 140
Self-citationIBD disease-modifying therapies: insights from emerging therapeutics
Kotla, N. G., & Rochev, Y. A. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.01.001 · Cited by 142
The Regulation of Intestinal Mucosal Barrier by Myosin Light Chain Kinase/Rho Kinases
Jin, Y., & Blikslager, A. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103550 · Cited by 139
Raju, P., Shashikanth, N., Tsai, P.-Y., Pongkorpsakol, P., Chánez-Paredes, S. D., Steinhagen, P., Kuo, W., Singh, G., Tsukita, S., & Turner, J. R. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138697 · Cited by 136
Self-citationAbraham, C., Abreu, M. T., & Turner, J. R. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.288 · Cited by 129
Self-citationCytokines and intestinal epithelial permeability: A systematic review
Meyer, F., Wendling, D., Demougeot, C., Prati, C., & Verhoeven, F. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103331 · Cited by 125
Wu, J., Zhu, Z., Liu, W., Zhang, Y., Kang, Y., Liu, J., Hu, C., Wang, R., Zhang, M., Chen, L., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c05317 · Cited by 110
Self-citationIntestinal Epithelial Tight Junction Barrier Regulation by Novel Pathways
Priya, A., Saha, K., & Nighot, P. K. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae232 · Cited by 115
A Weak Link with Actin Organizes Tight Junctions to Control Epithelial Permeability
Belardi, B., Hamkins-Indik, T., Harris, A. R., Kim, J., Xu, K., & Fletcher, D. A. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.07.022 · Cited by 96
Al-Sadi, R., Engers, J., Haque, M., King, S., Al-Omari, D., & Ma, T. Y. (2021) · PLOS ONE · doi:10.1371/journal.pone.0249544 · Cited by 93
Intestinal barrier dysfunction in severe burn injury
He, W., Wang, Y., Wang, P., & Wang, F. (2019) · Burns & Trauma · doi:10.1186/s41038-019-0162-3 · Cited by 93
Self-citationDuan, C., Kuang, L., Xiang, X., Zhang, J., Zhu, Y., Wu, Y., Yan, Q., Liu, L., & Li, T. (2020) · Aging · doi:10.18632/aging.102690 · Cited by 82
Scaffolding proteins of vertebrate apical junctions: structure, functions and biophysics
Rouaud, F., Sluysmans, S., Flinois, A., Shah, J., Vasileva, E., & Citi, S. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183399 · Cited by 84
Jurcău, M. C., Jurcău, A., Cristian, A., Hogea, V. O., Diaconu, R. G., & Nunkoo, V. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910535 · Cited by 100
The Epithelial Cell Leak Pathway
Monaco, A., Ovryn, B., Axis, J., & Amsler, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147677 · Cited by 81
The role of mucosal barriers in human gut health
Seo, K., Seo, J.-M., Yeun, J., Choi, H., Kim, Y., & Chang, S.-Y. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01327-5 · Cited by 76
Martínez-Sánchez, L. D. C., Ngo, P. A., Pradhan, R., Becker, L. S., Boehringer, D., Soteriou, D., Kubánková, M., Schweitzer, C., Koch, T., Thonn, V., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325520 · Cited by 80
Wang, X., Ni, J., You, Y., Feng, G., Zhang, S., Bao, W., Hou, H., Li, H., Liu, L., Zheng, M., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108080 · Cited by 71
Self-citationOami, T., Abtahi, S., Shimazui, T., Chen, C., Sweat, Y. Y., Liang, Z., Burd, E. M., Farris, A. B., Roland, J. T., Tsukita, S., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2217877121 · Cited by 74
Self-citationHaque, M., Kaminsky, L., Abdulqadir, R. F., Engers, J., Kovtunov, E., Rawat, M., Al-Sadi, R., & Ma, T. Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1348010 · Cited by 71
Kjer-Hansen, P., & Weatheritt, R. J. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01155-9 · Cited by 67
The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology
Buscarinu, M. C., Fornasiero, A., Romano, S., Ferraldeschi, M., Mechelli, R., Reniè, R., Morena, E., Romano, C., Pellicciari, G., Landi, A. C., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01916 · Cited by 68
Wang, J., Zhao, H., Lv, K., Zhao, W., Zhang, N., Yang, F., Wen, X., Jiang, X., Tian, J., Liu, X., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c00274 · Cited by 60
Xing, L., Liu, X., Wu, L., Wu, J., Deng, Y., Li, Q., Zhou, Z., Li, L., & Huang, Y. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102155 · Cited by 54
Self-citationPai, Y.-C., Weng, L.-T., Wei, S., Wu, L., Shih, D. Q., Targan, S. R., Turner, J. R., & Yu, L. C. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa165 · Cited by 51
Self-citationWall of Resilience: How the Intestinal Epithelium Prevents Inflammatory Onslaught in the Gut
Liebing, E., Krug, S. M., Neurath, M. F., Siegmund, B., & Becker, C. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.101423 · Cited by 52
Actin cytoskeleton dynamics during mucosal inflammation: a view from broken epithelial barriers
Lechuga, S., & Ivanov, A. I. (2020) · Current Opinion in Physiology · doi:10.1016/j.cophys.2020.06.012 · Cited by 51
Adrenomedullin: A Novel Therapeutic for the Treatment of Inflammatory Bowel Disease
Ashizuka, S., Kita, T., Inatsu, H., & Kitamura, K. (2021) · Biomedicines · doi:10.3390/biomedicines9081068 · Cited by 46
Marchelletta, R. R., Krishnan, M., Spalinger, M. R., Placone, T. W., Alvarez, R., Sayoc-Becerra, A., Canale, V., Shawki, A., Park, Y. S., Bernts, L. H. P., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci138230 · Cited by 46
Zuo, L., Kuo, W., Cao, F., Chánez-Paredes, S. D., Zeve, D., Mannam, P., Jean-François, L., Day, A., Graham, W. V., Sweat, Y. Y., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-326534 · Cited by 46
Self-citationType I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection
Labarta-Bajo, L., Nilsen, S. P., Humphrey, G., Schwartz, T., Sanders, K., Swafford, A. D.-E., Knight, R. D., Turner, J. R., & Zúñiga, E. I. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192276 · Cited by 42
Self-citationRamirez-Velez, I., & Belardi, B. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114905 · Cited by 46
Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms
Ciorba, M. A., Konnikova, L., Hirota, S. A., Lucchetta, E. M., Turner, J. R., Slavin, A., Johnson, K., Condray, C. D., Hong, S., Cressall, B. K., et al. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae081 · Cited by 44
Self-citationWu, Z., Zeng, H., Zhang, L., Pu, Y., Li, S., Yuan, Y. F., Zhang, T., & Wang, B. (2020) · Inflammation · doi:10.1007/s10753-020-01219-8 · Cited by 43
Wang, J., Lv, X., Li, Y., Wu, H., Chen, M., Yu, H., Wu, J., Li, C., & Xiong, W. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.11.065 · Cited by 42
Self-citationZongo, A. W., Zogona, D., Youssef, M., Ye, S., Zhan, F., Li, J., & Li, B. (2022) · Food & Function · doi:10.1039/d2fo02377f · Cited by 40
Oami, T., Shimazui, T., Yumoto, T., Otani, S., Hayashi, Y., & Coopersmith, C. M. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00786-y · Cited by 42
Kuai, Y., Liu, H., Liu, D., Liu, Y., Sun, Y., Xie, J., Sun, J., Fang, Y. H., Pan, H., & Han, W. (2020) · Theranostics · doi:10.7150/thno.43938 · Cited by 38
Lu, H., Li, H., Fan, C., Qi, Q., Yan, Y., Wu, Y., Feng, C., Wu, B., Gao, Y., Zuo, J., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113751 · Cited by 36
Self-citationImpacts of Fructose on Intestinal Barrier Function, Inflammation and Microbiota in a Piglet Model
Guo, P., Wang, H., Ji, L., Song, P., & Ma, X. (2021) · Nutrients · doi:10.3390/nu13103515 · Cited by 35
Tang, K., Wu, Z., Sun, M., Huang, X., Sun, J., Shi, J., Wang, X., Miao, Z., Gao, P., Song, Y., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2021.12.033 · Cited by 35
Cheng, M., Yang, Z. L., Qiao, L., Yang, Y., Deng, Y., Zhang, C., & Mi, T. (2022) · Gene · doi:10.1016/j.gene.2022.147030 · Cited by 32
IBD Matchmaking: Rational Combination Therapy
Battat, R. J., Chang, J. T., Loftus, E. V., & Sands, B. E. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.05.051 · Cited by 34
Transport functions of intestinal lymphatic vessels
Tso, P., Bernier‐Latmani, J., Petrova, T. V., & Liu, M. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00996-z · Cited by 33
Protein isoform-centric therapeutics: expanding targets and increasing specificity
Kjer-Hansen, P., Phan, T. G., & Weatheritt, R. J. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01025-z · Cited by 27
Bandyopadhyay, C., Schecterson, L. C., & Gumbiner, B. M. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.1940741 · Cited by 29
Fedorov, A. V., Chelombitko, M. A., Chernyavskij, D. A., Galkin, I. I., Pletjushkina, O. Y., Vasilieva, T. V., Zinovkin, R. A., & Chernyak, B. V. (2022) · Cells · doi:10.3390/cells11213441 · Cited by 33
Myosin Motors: Novel Regulators and Therapeutic Targets in Colorectal Cancer
Naydenov, N. G., Lechuga, S., Huang, E. H., & Ivanov, A. I. (2021) · Cancers · doi:10.3390/cancers13040741 · Cited by 30
Mauduit, A., Mas, E., Tapias, N. S., Ménard, S., & Barreau, F. (2025) · Journal of Gastroenterology · doi:10.1007/s00535-025-02289-x · Cited by 30
Jiang, N., Wei, Y., Cen, Y., Shan, L., Zhang, Z., Yu, P., Wang, Y., & Xu, L. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117164 · Cited by 26
Self-citationLucchinetti, E., Lou, P., Wawrzyniak, P., Wawrzyniak, M., Scharl, M. M., Holtzhauer, G., Krämer, S. D., Hersberger, M., Rogler, G., & Zaugg, M. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901270 · Cited by 29
The Role of Nutritional Factors and Intestinal Microbiota in Rheumatoid Arthritis Development
Alpizar-Rodriguez, D., Finckh, A., & Gilbert, B. T. P. (2020) · Nutrients · doi:10.3390/nu13010096 · Cited by 28
Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions
Ban, Q.-Y., Liu, M., Ding, N., Chen, Y., Lin, Q., Zha, J., & He, W. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.794169 · Cited by 26
Self-citationDeciphering internal and external factors influencing intestinal junctional complexes
Markovich, Z., Abreu, A., Sheng, Y., Han, S. M., & Xiao, R. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2389320 · Cited by 26
Wang, F., Wang, D., Song, M., Zhou, Q., Liao, R., & Wang, Y. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1707229 · Cited by 24
Self-citationPongkorpsakol, P., Turner, J. R., & Zuo, L. (2020) · Current Protocols in Immunology · doi:10.1002/cpim.112 · Cited by 23
Self-citationTsukita, K., Yano, T., Tamura, A., & Tsukita, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236012 · Cited by 25
Lamisere, H., Bhalchandra, S., Kane, A. V., Zeng, X., Mo, D., Adams, W., Estes, M. K., & Ward, H. (2022) · Infection and Immunity · doi:10.1128/iai.00397-22 · Cited by 22
Heindryckx, F., & Sjöblom, M. (2024) · Acta Physiologica · doi:10.1111/apha.14188 · Cited by 21
Saha, K., Zhou, Y., & Turner, J. R. (2024) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001066 · Cited by 21
Self-citationMeng, Y., Wáng, Q., Ma, Z., Li, W., Niu, K., Zhu, T., Lin, H., Lu, C., & Fan, H. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010765 · Cited by 21
Phase separation of an actin nucleator by junctional microtubules regulates epithelial function
Tsukita, K., Kitamata, M., Kashihara, H., Yano, T., Fujiwara, I., Day, T. F., Katsuno, T., Kim, J., Takenaga, F., Tanaka, H., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf6358 · Cited by 21
Pongkorpsakol, P., Satianrapapong, W., Wongkrasant, P., Steinhagen, P., Tuangkijkul, N., Pathomthongtaweechai, N., & Muanprasat, C. (2021) · Methods in molecular biology · doi:10.1007/7651_2021_347 · Cited by 20
Intestinal Membrane Function in Inflammatory Bowel Disease
Nakai, D., & Miyake, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics16010029 · Cited by 20
Bao, W., Lyu, J., Feng, G., Guo, L., Zhao, D., You, K., Liu, Y., Li, H., Du, P., Chen, D., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.05.027 · Cited by 18
Self-citationGhosh, S., Singh, R., Goap, T. J., Sunnapu, O., Vanwinkle, Z. M., Li, H., Nukavarapu, S. P., Dryden, G. W., Haribabu, B., Vemula, P. K., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02990-8 · Cited by 18
Self-citationWang, H., Xing, H., Xia, Y., Zhou, Y., Zhou, J., Li, L., Tao, W., Liu, Q., Wang, Y., Zhao, J., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109025 · Cited by 16
Self-citationAbdulqadir, R. F., Al–Sadi, R., Haque, M. R., Gupta, Y., Rawat, M., & Ma, T. Y. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.05.012 · Cited by 19
HO‐1/CO Maintains Intestinal Barrier Integrity through NF‐κB/MLCK Pathway in Intestinal HO‐1-/- Mice
Zhang, Z., Zhang, L., Zhang, Q., Liu, B., Li, F., Xin, Y., & Duan, Z. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6620873 · Cited by 16
Chánez-Paredes, S. D., Abtahi, S., Zha, J., Li, E., Marsischky, G., Zuo, L., Grey, M. J., He, W., & Turner, J. R. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105643 · Cited by 15
Self-citationNovel pH-responsive and CD44-targeting silica nanoparticles for inflammatory bowel disease therapy
Li, W., Cai, J., Gu, Y., Li, X., He, W.-J., Chen, Y., Wang, Z., Li, K., Qin, G., Gu, X., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.163017 · Cited by 15
Self-citationYao, Y., Feng, Q., & Shen, J. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1850269 · Cited by 15
Intestinal barrier in inflammatory bowel disease: A bibliometric and knowledge-map analysis
Zhou, F., Wu, N.-Z., Xie, Y., & Zhou, X. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i36.5254 · Cited by 15
Liang, B., Wu, C., Wang, C., Sun, W., Chen, W., Hu, X., Liu, N., & Xing, D. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1065608 · Cited by 15
Effects of proton pump inhibitors on inflammatory bowel disease: An updated review
Liang, Y., Meng, Z., Ding, X., & Jiang, M. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i21.2751 · Cited by 14
Sun, Y., Oami, T., Liang, Z., Miniet, A. A., Burd, E. M., Ford, M. L., & Coopersmith, C. M. (2021) · Shock · doi:10.1097/shk.0000000000001759 · Cited by 14
Wang, Z., Lin, J.-Y., Feng, Y.-R., Liu, D.-S., Zhao, X., Li, T., Li, S., Sun, J.-C., Li, S., Jia, W.-Y., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i32.5404 · Cited by 14
The Effect of Protein Nutritional Support on Inflammatory Bowel Disease and Its Potential Mechanisms
Li, Q., & Wang, J. (2024) · Nutrients · doi:10.3390/nu16142302 · Cited by 14
Yumoto, T., Oami, T., Liang, Z., Burd, E. M., Ford, M. L., Turner, J. R., & Coopersmith, C. M. (2024) · Shock · doi:10.1097/shk.0000000000002531 · Cited by 13
Self-citationLi, Z., Luo, H.-Y., Xu, F., Xu, Y., Ma, C., Zhang, S.-L., Xu, S., Ma, Y.-Y., Li, N., & Miao, C. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02457-1 · Cited by 12
Prospects for macrolide therapy of asthma and COPD
Parnham, M. J., Norris, V., Kricker, J. A., Guðjónsson, Þ., & Page, C. P. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2023.03.002 · Cited by 12
Prediction and Prevention of Inflammatory Bowel Disease
Lopes, E. W., Turpin, W., Croitoru, K., Colombel, J., & Torres, J. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.05.047 · Cited by 13
Du, L., Jiang, W., Zhu, X., Zhu, L., Fan, Y., & Jiang, W. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113462 · Cited by 16
Balancing Tumor Immunotherapy and Immune-Related Adverse Events: Unveiling the Key Regulators
Huang, J., Xiong, L., Tang, S., Zhao, J., & Zuo, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010919 · Cited by 11
Oami, T., Yumoto, T., Shimazui, T., Sarmiento, S., Klingensmith, N. J., Chen, C., Otani, S., Liang, Z., Burd, E. M., Mahdi, Z. K., et al. (2023) · Shock · doi:10.1097/shk.0000000000002162 · Cited by 12
Metadata
- Authors
- Graham, W. V., He, W., Marchiando, A. M., Zha, J., Singh, G., Li, H.-S., Biswas, A., Ong, M. L. D. M., Jiang, Z.-H., Choi, W., Zuccola, H., Wang, Y., Griffith, J., Wu, J., Rosenberg, H. J., Wang, Y., Snapper, S. B., Ostrov, D., Meredith, S. C., Miller, L. W., & Turner, J. R.
- Affiliations
- University of Chicago (US)
- Soochow University (CN)
- Brigham and Women's Hospital (US)
- Boston Children's Hospital (US)
- Vertex Pharmaceuticals (United States) (US)
- University of Florida (US)
- University of Illinois Chicago (US)
- Corresponding author
- Turner, Jerrold R.
- ORCID
- Venue
- Nature Medicine
- Published
- 2019-04
- Volume
- 25
- Issue
- 4
- Pages
- 690-700
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC6461392
- OpenAlex
- W2933961522
- Cited by
- 176
- References
- 56
- Citations by year
- 2026: 22 · 2025: 20 · 2024: 37 · 2023: 17 · 2022: 26 · 2021: 23 · 2020: 21 · 2019: 9
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- University of Illinois Chicago
- Funders
- Crohn's and Colitis Foundation (310801)
- National Institute on Aging (R01AG048793)
- National Heart, Lung, and Blood Institute (T32HL007237)
- National Cancer Institute (P30CA014599)
- National Institute of General Medical Sciences (R01GM081030)
- National Institute of Diabetes and Digestive and Kidney Diseases (R56DK094954, R24DK099803, R01DK068271, P30DK034854, R01DK061931)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- myosin light chain kinase, epithelial barrier dysfunction, small molecule inhibitors, myosin light chain phosphorylation, inflammatory bowel disease, diarrhea, mucosal homeostasis
- MeSH terms
- Protein Domains, Actomyosin, Animals, Chronic Disease, Homeostasis, Humans, Inflammation, Intestinal Mucosa, Jejunum, Myosin-Light-Chain Kinase, Phosphorylation, Tumor Necrosis Factor-alpha, Inflammatory Bowel Diseases, Caco-2 Cells, Myosin Light Chains, Tight Junctions, Intracellular Space, Mice, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review